Pathos logo

Pathos

Chicago, IL

Pathos develops an AI-enabled drug discovery platform to reduce the medication development process. Its self-learning platform utilizes big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy. It also helps drug developers to explore novel concepts, and advance breakthrough therapies. The company's OS platform is capable of managing the entire end-to-end process of designing and developing novel therapeutics.

pathos.com

Company Details

Founded

2020

Employees

Between 10 - 100 employees

Raised

$447,000,000

Headquarters Location

Chicago, IL

Public

No

Acquired

No

CEO

Ryan Fukushima

Founders

Ryan Fukushima
Eric Lefkofsky
Eric Lefkofsky

Company Collections

These are collections Pathos is a part of. Click on the collection name to view similar companies.

Pathos' Industries

Pathos' Tech Stack

Pathos Headquarters Location

600 West Chicago Avenue suite 510, Chicago, IL 60654

Total Amount Raised: $447,000,000

Pathos Funding Rounds

  • Series D

    $365,000,000

  • Series C

    $62,000,000

    Series C Investors

    NEA - New Enterprise Associates
    Revolution
    Builders VC
    Lightbank

  • Series Unknown

    $19,999,992

Funding info provided by Diffbot.

Pathos Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Pathos.

Recent reviews